Gene Expression Assays Test Market Overview

The report is titled ‘Gene Expression Assays Test Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the gene expression assays test market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. The gene expression assays test market is expected to grow at a significant rate in the near future.

Gene Expression Assays Test Market Definition

Gene expression can be perceived as the method by which the information encrypted in a gene is employed to conduct the convocation of a protein molecule. The fresh technological advancements create an opportunity to examine the expression of the whole genome in a sole experiment. These "gene expression assays" enhance or substitute earlier assays which assessed the gene expression of only a single gene, or a selected bunch of genes.

Gene Expression Assays Test Market Dynamics

Genomic tests examine a specimen of a cancer tumor to observe the movement and actions of a certain genes. The action level of these genes influences the demeanour of the cancer, also comprising the possibility of it growing and spreading. Genetic testing is performed on a specimen of an individual’s saliva, blood, or other tissue to observe if the body has an abnormal alteration (also known as a mutation) in a gene that is combined to a greater risk of breast cancer.

The rising prevalence of cancer among the population, specifically breast cancer, is majorly driving the demand of gene expression assays test across the global markets, which in turn, is projected to boost the growth of the global gene expression assays test market in the years to come. In addition to that, the constant research activities in the field of genomics and associated increasing application areas of genomics is further fueling the growth in demand of gene expression assays tests across the world. Attributing to which, the global gene expression assays test market is estimated to witness massive breakthroughs in the forthcoming years.

However, lack of medical professionals and expertise in this specific field, particularly in emerging economies, is likely to curb the growth of the global gene expression assays test market over the forecast period.

Gene Expression Assays Test Market Segmentation

The global gene expression assays test market is segmented on the basis of test, end-user, and by region.

By Test

Oncotype DX

MammaPrint

PAM50/Prosigna

EndoPredict

MapQuant Dx

IHC4

Theros-Breast Cancer Gene Expression Ratio Assay

By End-User

Hospitals & Clinics

Diagnostic Centers and Medical Laboratories

Others

By Region

North America

Latin America

Europe

Africa

Middle East

Asia Pacific

Gene Expression Assays Test Market Key Players

The key participating players of the global gene expression assays test market include Palex Group, Thermo Fisher Scientific, Exact Sciences UK, Ltd., Medilinks Inc., Genomic Health, Inc., Agendia NV, Veracyte, Inc., NeoGenomics, NanoString, Myriad Genetics, Qiagen, Biogenex, BioTheranostics, Inc., among others.

MMC Overview on Gene Expression Assays Test Market Report

The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give a better opportunity for the customers to put their effort.

A research report on the Gene Expression Assays Test market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that support the market and the factors that are acting as impedance for the growth of the market.

Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth includes (but not restricted to):

New product designs and launches

Current product compliance

Reimbursement

Concerns for use of Gene Expression Assays Test

Advantages of Gene Expression Assays Test

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to make informed decisions.

A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment where one/two manufacturer(s) dominates the market, it’s product sales, previous growth rates and market expansion plans are considered to generate market share in the global market.

1.    Global Gene Expression Assays Test Market Report Overview

1.1.    Introduction

1.2.    Report Description

1.3.    Methodology

2.    Global Gene Expression Assays Test Market Overview

2.1.    Introduction

2.1.1.    Market Definition

2.1.2.    Market Taxonomy

2.2.    Executive Summary

2.3.    Global Gene Expression Assays Test Market Snapshot

2.4.    Global Gene Expression Assays Test Market Size And Forecast, 2020–2028

2.4.1.    Introduction

2.4.2.    Market Value Forecast And Annual Growth Rate (AGR) Comparison (2020–2028)

2.5.    Global Gene Expression Assays Test Market Dynamics

2.5.1.    Drivers

2.5.2.    Restraints

2.5.3.    Opportunity

2.5.4.    Trends

2.6.    Porter’s Five Forces Model

2.7.    SWOT Analysis

3.    Gene Expression Assays Test Assessment and Analysis

3.1.    Gene Expression Assays Test Impact Analysis 

3.2.    Actions to encourage use of Gene Expression Assays Test

3.3.    Gene Expression Assays Test Promotional Strategy Recommendation

3.4.    Road Map Analysis

3.5.    Potential Analysis

4.    Covid-19 Impact on Gene Expression Assays Test Market

4.1.    Impact Analysis of Covid-19 on the global Gene Expression Assays Test market

4.2.    Effect On Value Chain

4.3.    Business Impact W.R.T Revenue 

4.4.    Volatility In Price 

4.5.    Effect On The Overall Trade 

4.6.    Market Impact Analysis In 2020 (Quarter Wise)

5.    Global Gene Expression Assays Test Market, By Test

5.1.    Introduction

5.1.1.    Annual Growth Rate Comparison, By Test

5.1.2.    BPS Analysis, By Test

5.2.    Market Revenue (US$Mn) and Forecast, By Test

5.2.1.    Oncotype DX

5.2.2.    MammaPrint

5.2.3.    PAM50/Prosigna

5.2.4.    EndoPredict

5.2.5.    MapQuant Dx

5.2.6.    IHC4

5.2.7.    Theros-Breast Cancer Gene Expression Ratio Assay

5.3.     Global Gene Expression Assays Test Market Attractiveness Index, By Test

6.    Global Gene Expression Assays Test Market, By End User

6.1.    Introduction

6.1.1.    Annual Growth Rate Comparison, By End User

6.1.2.    BPS Analysis, By End User

6.2.    Market Revenue (US$Mn) and Forecast, By End User

6.2.1.    Hospitals & Clinics

6.2.2.    Diagnostic Centers and Medical Laboratories

6.2.3.    Others

6.3.     Global Gene Expression Assays Test Market Attractiveness Index, By End User

7.    Global Gene Expression Assays Test Market, By Region

7.1.    Introduction

7.1.1.    Annual Growth Rate Comparison, By Region

7.1.2.    BPS Analysis, By Region

7.2.    Market Revenue (US$Mn) and Forecast, By Region

7.2.1.    North America

7.2.2.    Latin America

7.2.3.    Europe

7.2.4.    Asia Pacific

7.2.5.    Middle East 

7.2.6.    Africa

7.3.    Global Gene Expression Assays Test Market Attractiveness Index, By Region

8.    North America Gene Expression Assays Test Market Analysis and Forecast, 2020–2028

8.1.    Introduction

8.1.1.    Annual Growth Rate Comparison, By Country

8.1.2.    BPS Analysis, By Country

8.2.    Market Revenue (US$Mn) and Forecast, By Country

8.2.1.    U.S. Gene Expression Assays Test Market

8.2.2.    Canada Gene Expression Assays Test Market

8.3.    North America Gene Expression Assays Test Market, By Test 

8.3.1.    Oncotype DX

8.3.2.    MammaPrint

8.3.3.    PAM50/Prosigna

8.3.4.    EndoPredict

8.3.5.    MapQuant Dx

8.3.6.    IHC4

8.3.7.    Theros-Breast Cancer Gene Expression Ratio Assay

8.4.    North America Gene Expression Assays Test Market, By End User

8.4.1.    Hospitals & Clinics

8.4.2.    Diagnostic Centers and Medical Laboratories

8.4.3.    Others

8.5.    North America Gene Expression Assays Test Market Attractiveness Index

8.5.1.    By Country

8.5.2.    By Test

8.5.3.    By End User

9.    Latin America Gene Expression Assays Test Market Analysis and Forecast, 2020–2028

9.1.    Introduction

9.1.1.    Annual Growth Rate Comparison, By Country

9.1.2.    BPS Analysis, By Country

9.2.    Market (US$Mn) Forecast, By Country

9.2.1.    Brazil Gene Expression Assays Test Market

9.2.2.    Mexico Gene Expression Assays Test Market

9.2.3.    Rest Of Latin America Gene Expression Assays Test Market

9.3.    Latin America Gene Expression Assays Test Market, By Test 

9.3.1.    Oncotype DX

9.3.2.    MammaPrint

9.3.3.    PAM50/Prosigna

9.3.4.    EndoPredict

9.3.5.    MapQuant Dx

9.3.6.    IHC4

9.3.7.    Theros-Breast Cancer Gene Expression Ratio Assay

9.4.    Latin America Gene Expression Assays Test Market, By End User

9.4.1.    Hospitals & Clinics

9.4.2.    Diagnostic Centers and Medical Laboratories

9.4.3.    Others

9.5.    Latin America Gene Expression Assays Test Market Attractiveness Index

9.5.1.    By Country

9.5.2.    By Test

9.5.3.    By End User

10.    Europe Gene Expression Assays Test Market Analysis and Forecast, 2020–2028

10.1.    Introduction

10.1.1.    Annual Growth Rate Comparison, By Country

10.1.2.    BPS Analysis, By Country

10.2.    Market (US$Mn) Forecast, By Country

10.2.1.    U.K. Gene Expression Assays Test Market

10.2.2.    Germany Gene Expression Assays Test Market

10.2.3.    Italy Gene Expression Assays Test Market

10.2.4.    France Gene Expression Assays Test Market

10.2.5.    Spain Gene Expression Assays Test Market

10.2.6.    Russia Gene Expression Assays Test Market

10.2.7.    Rest Of Europe Gene Expression Assays Test Market

10.3.    Europe Gene Expression Assays Test Market, By Test 

10.3.1.    Oncotype DX

10.3.2.    MammaPrint

10.3.3.    PAM50/Prosigna

10.3.4.    EndoPredict

10.3.5.    MapQuant Dx

10.3.6.    IHC4

10.3.7.    Theros-Breast Cancer Gene Expression Ratio Assay

10.4.    Europe Gene Expression Assays Test Market, By End User

10.4.1.    Hospitals & Clinics

10.4.2.    Diagnostic Centers and Medical Laboratories

10.4.3.    Others

10.5.    Europe Gene Expression Assays Test Market Attractiveness Index

10.5.1.    By Country

10.5.2.    By Test

10.5.3.    By End User

11.    Asia Pacific Gene Expression Assays Test Market Analysis and Forecast, 2020–2028

11.1.    Introduction

11.1.1.    Annual Growth Rate Comparison, By Country

11.1.2.    BPS Analysis, By Country

11.2.    Market (US$Mn) Forecast, By Country

11.2.1.    China Gene Expression Assays Test Market

11.2.2.    India Gene Expression Assays Test Market

11.2.3.    Japan Gene Expression Assays Test Market

11.2.4.    Australia and New Zealand Gene Expression Assays Test Market

11.2.5.    South Korea Gene Expression Assays Test Market

11.2.6.    Rest of Asia Pacific Gene Expression Assays Test Market

11.3.    Asia Pacific Gene Expression Assays Test Market, By Test 

11.3.1.    Oncotype DX

11.3.2.    MammaPrint

11.3.3.    PAM50/Prosigna

11.3.4.    EndoPredict

11.3.5.    MapQuant Dx

11.3.6.    IHC4

11.3.7.    Theros-Breast Cancer Gene Expression Ratio Assay

11.4.    Asia Pacific Gene Expression Assays Test Market, By End User

11.4.1.    Hospitals & Clinics

11.4.2.    Diagnostic Centers and Medical Laboratories

11.4.3.    Others

11.5.    Asia Pacific Gene Expression Assays Test Market Attractiveness Index

11.5.1.    By Country

11.5.2.    By Test

11.5.3.    By End User

12.    Middle East Gene Expression Assays Test Market Analysis and Forecast, 2020–2028

12.1.    Introduction

12.1.1.    Annual Growth Rate Comparison, By Country

12.1.2.    BPS Analysis, By Country

12.2.    Market (US$Mn) Forecast, By Country

12.2.1.    GCC Countries Gene Expression Assays Test Market

12.2.2.    Israel Gene Expression Assays Test Market

12.2.3.    Rest Of Middle East Gene Expression Assays Test Market

12.3.    Middle East Gene Expression Assays Test Market, By Test 

12.3.1.    Oncotype DX

12.3.2.    MammaPrint

12.3.3.    PAM50/Prosigna

12.3.4.    EndoPredict

12.3.5.    MapQuant Dx

12.3.6.    IHC4

12.3.7.    Theros-Breast Cancer Gene Expression Ratio Assay

12.4.    Middle East Gene Expression Assays Test Market, By End User

12.4.1.    Hospitals & Clinics

12.4.2.    Diagnostic Centers and Medical Laboratories

12.4.3.    Others

12.5.    Middle East Gene Expression Assays Test Market Attractiveness Index

12.5.1.    By Country

12.5.2.    By Test

12.5.3.    By End User

13.    Africa Gene Expression Assays Test Market Analysis and Forecast, 2020–2028

13.1.    Introduction

13.1.1.    Annual Growth Rate Comparison, By Country

13.1.2.    BPS Analysis, By Country

13.2.    Market (US$Mn) Forecast, By Country

13.2.1.    South Africa Countries Gene Expression Assays Test Market

13.2.2.    Egypt Gene Expression Assays Test Market

13.2.3.    North Africa Gene Expression Assays Test Market

13.2.4.    Rest of Africa Gene Expression Assays Test Market

13.3.    Africa Gene Expression Assays Test Market, By Test 

13.3.1.    Oncotype DX

13.3.2.    MammaPrint

13.3.3.    PAM50/Prosigna

13.3.4.    EndoPredict

13.3.5.    MapQuant Dx

13.3.6.    IHC4

13.3.7.    Theros-Breast Cancer Gene Expression Ratio Assay

13.4.    Africa Gene Expression Assays Test Market, By End User

13.4.1.    Hospitals & Clinics

13.4.2.    Diagnostic Centers and Medical Laboratories

13.4.3.    Others

13.5.    Africa Gene Expression Assays Test Market Attractiveness Index

13.5.1.    By Country

13.5.2.    By Test

13.5.3.    By End User

14.    Competitive Landscape

14.1.    Competition Dashboard

14.2.    Company Profiles

14.2.1.    Palex Group

14.2.1.1.    Company Overview

14.2.1.2.    Financial Overview

14.2.1.3.    Key Developments

14.2.1.4.    Strategies

14.2.1.5.    Product Analysis

14.2.2.    Thermo Fisher Scientific

14.2.3.    Exact Sciences UK, Ltd.

14.2.4.    Medilinks Inc.

14.2.5.    Genomic Health, Inc.

14.2.6.    Agendia NV

14.2.7.    Veracyte, Inc.

14.2.8.    NeoGenomics

14.2.9.    NanoString

14.2.10.    Myriad Genetics

14.2.11.    Qiagen

14.2.12.    Biogenex

14.2.13.    BioTheranostics, Inc.

15.    Acronyms